Evidence map›Paper›PMID 32827587›Full record

ArticleResuscitation2020

Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice.

Jamie J Coleman, Adam Botkai, Ella J Marson, Felicity Evison, Jolene Atia, Jingyi Wang, Suzy Gallier, John Speakman, Tanya Pankhurst

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Resuscitation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jamie J ColemanUniversity Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TT, UK; School of Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2SP, UK. Electronic address: j.j.coleman@bham.ac.uk.
Adam BotkaiUniversity Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TT, UK; School of Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2SP, UK.
Ella J MarsonUniversity Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TT, UK; School of Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2SP, UK.
Felicity EvisonUniversity Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TT, UK.
Jolene AtiaUniversity Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TT, UK.
Jingyi WangUniversity Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TT, UK.
Suzy GallierUniversity Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TT, UK.
John SpeakmanUniversity Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TT, UK.
Tanya PankhurstUniversity Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TT, UK.
University Hospitals Birmingham NHS Foundation Trust · GBUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has introduced further challenges into Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) decisions. Existing evidence suggests success rates for CPR in COVID-19 patients is low and the risk to healthcare professionals from this aerosol-generating procedure complicates the benefit/harm balance of CPR.

methodsThe study is based at a large teaching hospital in the United Kingdom where all DNACPR decisions are documented on an electronic healthcare record (EHR). Data from all DNACPR/TEAL status forms between 1st January 2017 and 30th April 2020 were collected and analysed. We compared patterns of decision making and rates of form completion during the 2-month peak pandemic phase to an analogous period during 2019.

resultsA total of 16,007 forms were completed during the study period with a marked increase in form completion during the COVID-19 pandemic. Patients with a form completed were on average younger and had fewer co-morbidities during the COVID-19 period than in March-April 2019. Several questions on the DNACPR/TEAL forms were answered significantly differently with increases in patients being identified as suitable for CPR (23.8% versus 9.05%; p < 0.001) and full active treatment (30.5% versus 26.1%; p = 0.028). Whilst proportions of discussions that involved the patient remained similar during COVID-19 (95.8% versus 95.6%; p = 0.871), fewer discussions took place with relatives (50.6% versus 75.4%; p < 0.001).

conclusionDuring the COVID-19 pandemic, the emphasis on senior decision making and conversations around ceilings of treatment appears to have changed practice, with a higher proportion of patients having DNACPR/TEAL status documented. Understanding patient preferences around life-sustaining treatment versus comfort care is part of holistic practice and supports shared decision making. It is unclear whether these attitudinal changes will be sustained after COVID-19 admissions decrease.

Indexed as

AgedCardiopulmonary ResuscitationClinical Decision-MakingCohort StudiesCoronavirus InfectionsCOVID-19Critical IllnessDatabases, FactualDelivery of Health CareFemaleHospital MortalityHospitals, TeachingHumansIncidenceMaleMiddle AgedAdvance directivesCOVID-19Electronic health recordsResuscitation orders

Identifiers

PMID32827587
PMCPMC7438269
OpenAlexW3070445843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.